Yield10 Bioscience (YTEN) has provided an announcement.
At Yield10 Bioscience, Inc.’s 2024 Annual Meeting, stockholders made several key decisions affecting the company’s future. They authorized increasing the common stock pool by 10,416 shares under the 2018 Plan, adjusted for a prior reverse stock split, and approved raising the authorized shares from 60 million to 150 million. Directors were reelected, the appointment of an accounting firm was ratified, executive compensation was approved, and it was determined that such compensation votes would occur every three years. Additionally, the issuance of shares for warrant exercises and amendments to the 2018 Plan were sanctioned.
For a thorough assessment of YTEN stock, go to TipRanks’ Stock Analysis page.
